Abstract
AMPK can either inhibit or promote tumor growth depending on tumor type and context. Eichner et al. show that AMPK, unlike LKB1, has a pro-tumorigenic role in a Kras-dependent, non-small-cell lung cancer model through the regulation of Tfe3, a master regulator of lysosomes, which supports lung tumor growth.
Original language | English (US) |
---|---|
Pages (from-to) | 285-302.e7 |
Journal | Cell Metabolism |
Volume | 29 |
Issue number | 2 |
DOIs | |
State | Published - Feb 5 2019 |
Funding
This study was supported by grants to R.J.S. from the National Institutes of Health ( R35CA220538 , P01CA120964 ) and the Samuel Waxman Cancer Research Foundation and by The Leona M. and Harry B. Helmsley Charitable Trust grant # 2012-PG-MED002 . R.U.S. is supported by a postdoctoral fellowship from the American Cancer Society (ACS# 124183-PF-13-023-01-CSM ). L.J.E. is supported by a postdoctoral fellowship from the American Cancer Society ( PF-15-037-01-DMC ). S.N.B was supported by training grant 5T32CA009370 to the Salk Institute Cancer Center and 5F32CA206400 . The Salk CCSG P30 CA014195 and Helmsley Charitable Trust supported the Functional Genomics Core and the Bioinformatics Core, as well as providing partial support for K. McIntyre and the histology core of the Salk Institute.
Keywords
- AMPK
- Kras
- LKB1
- Tfe3
- Tfeb
- cancer
- lung
- lysosomes
- metabolism
- tumor
ASJC Scopus subject areas
- Physiology
- Molecular Biology
- Cell Biology